| 000 | 01555 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250515194800.0 | ||
| 264 | 0 | _c20100201 | |
| 008 | 201002s 0 0 eng d | ||
| 022 | _a1879-1913 | ||
| 024 | 7 |
_a10.1016/j.amjcard.2009.07.028 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIto, Takahide | |
| 245 | 0 | 0 |
_aUsefulness of carvedilol to abolish myocardial postsystolic shortening in patients with idiopathic dilated cardiomyopathy. _h[electronic resource] |
| 260 |
_bThe American journal of cardiology _cDec 2009 |
||
| 300 |
_a1568-73 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xtherapeutic use |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCarbazoles _xtherapeutic use |
| 650 | 0 | 4 |
_aCardiomyopathy, Dilated _xdiagnostic imaging |
| 650 | 0 | 4 | _aCarvedilol |
| 650 | 0 | 4 |
_aDiastole _xdrug effects |
| 650 | 0 | 4 | _aEchocardiography, Doppler |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPropanolamines _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVentricular Dysfunction, Left _xprevention & control |
| 650 | 0 | 4 |
_aVentricular Function, Left _xdrug effects |
| 700 | 1 | _aKawanishi, Yasunori | |
| 700 | 1 | _aFutai, Rie | |
| 700 | 1 | _aTerasaki, Fumio | |
| 700 | 1 | _aKitaura, Yasushi | |
| 773 | 0 |
_tThe American journal of cardiology _gvol. 104 _gno. 11 _gp. 1568-73 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.amjcard.2009.07.028 _zAvailable from publisher's website |
| 999 |
_c19317529 _d19317529 |
||